Get the Stockscreener App
0.6968
0.46%
-0.00325
After Hours:
.70
0.00325
+0.47%
Gelteq Ltd stock is traded at $0.6968, with a volume of 13,423.
It is down -0.46% in the last 24 hours and down -10.67% over the past month.
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
See More
Previous Close:
$0.70
Open:
$0.695
24h Volume:
13,423
Relative Volume:
0.02
Market Cap:
$7.46M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-1.8877
EPS:
-0.3691
Net Cash Flow:
-
1W Performance:
+4.65%
1M Performance:
-10.67%
6M Performance:
-45.14%
1Y Performance:
-25.08%
1-Day Range:
$0.69
$0.70
1-Week Range:
$0.663
$0.77
52-Week Range:
$0.6401
$4.11
Gelteq Ltd Stock (GELS) Company Profile
Compare GELS vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GELS
Gelteq Ltd
|
0.6968 | 7.45M | 0 | 0 | 0 | -0.3691 |
TAK
Takeda Pharmaceutical Co Adr
|
17.85 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
121.11 | 49.56B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.86B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.77 | 35.89B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
578.54 | 25.06B | 3.18B | 1.33B | 1.04B | 27.90 |
Gelteq Ltd Stock (GELS) Latest News
ETF Watch: Is Gelteq Limited likely to announce a buyback2026 Earnings Surprises & Low Risk High Reward Ideas - baoquankhu1.vn
Market Review: How liquid is Gelteq Limited stockExit Point & Consistent Income Trade Recommendations - baoquankhu1.vn
Gelteq Ltd (GELS) Cash Flow - TradingKey
GELS PE Ratio & Valuation, Is GELS Overvalued - Intellectia AI
Five straight record quarters set up Healthy Extracts for a bigger 2026 - Stock Titan
Short Interest in Gelteq Limited Drops 26.3% in March - National Today
Travel Stocks: How does Gelteq Limited compare to its peers2026 Analyst Calls & Safe Capital Growth Stock Tips - baoquankhu1.vn
Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound - MSN
Gelteq receives Nasdaq notice for minimum bid price deficiency By Investing.com - za.investing.com
Gelteq receives Nasdaq notice for minimum bid price deficiency - Investing.com
Nasdaq warns Gelteq (NASDAQ: GELS) after shares stay below $1.00 - Stock Titan
[Form 3] Gelteq Ltd Initial Statement of Beneficial Ownership - Stock Titan
Gelteq (NASDAQ: GELS) director reports family trust-held positions - Stock Titan
Gelteq Ltd (GELS) officer discloses 500,000 trust-held shares on Form 3 - Stock Titan
Gelteq Ltd (GELS) CEO details indirect share and note holdings - Stock Titan
GELS Should I Buy - Intellectia AI
Retail Trends: Will Gelteq Limited outperform small cap indexesTrade Signal Summary & Comprehensive Market Scan Insights - baoquankhu1.vn
Will Gelteq Limited stock hit new highs in YEAR2025 Key Highlights & Growth Focused Entry Reports - mfd.ru
Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership - The Manila Times
IPO Launch: Can Gelteq Limited outperform in the next rallyQuarterly Risk Review & Safe Investment Capital Preservation Plans - baoquankhu1.vn
HUB Cyber Security Receives Compliance Notice from Nasdaq - Intellectia AI
YYAI Director Hongyu Zhou Acquires 4.215M Shares at $1.37, Totaling $5.77M - Intellectia AI
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Inspire Veterinary Partners Stock Drops Amid Market Weakness - Intellectia AI
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Gelteq (NASDAQ:GELS) Trading Up 6.9% – What’s Next? - Defense World
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Trump: Netflix-Paramount Skydance-Warner Bros. Deal? Watch TOON, SEGG, ASST, GELS Small-Cap Stocks - FinancialContent
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
GELS Stock: Market Movements Reflect Strategic Challenges - StocksToTrade
Gelteq announces preclinical results on medicinal cannabinoid absorption - Yahoo Finance
Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Tumble Ahead Of SC Ruling On Trump's Tariffs— Wells Fargo, BP, WeRide In Focus (UPDATED) - Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Gelteq Ltd Reports 22% Bioavailability Increase in Cannabinoid Oral Gel, Shares Surge 50.1% - Intellectia AI
Why Gelteq Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket - Benzinga
Stock Market Today: Dow Jones, Nasdaq 100 Futures Tumble Ahead Of Supreme Court Ruling On Trump's Tariffs—Wells Fargo, BP, WeRide In Focus - Benzinga
Bank of America, Citigroup And 3 Stocks To Watch Heading Into Wednesday - Benzinga
Gelteq reports improved CBD bioavailability with oral gel platform By Investing.com - Investing.com Nigeria
What's Driving Gelteq Ltd.'s (GELS) Over 69% After-Hours Surge? - Benzinga
Will Gelteq Limited outperform small cap indexesJuly 2025 Momentum & High Yield Equity Trading Tips - baoquankhu1.vn
These stocks are moving in today's after hours session - Chartmill
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Gelteq Preclinical Results Show Increased Medicinal Cannabinoid Absorption - Cannabis Business Times
Gelteq reports improved CBD bioavailability with oral gel platform - Investing.com
Gelteq Announces Positive Preclinical Results Showing Increased Medicinal Cannabinoid Absorption Using Its Oral Gel Delivery Platform - The Manila Times
Gel-based medicinal cannabis boosts CBD uptake 22%+ in early tests - Stock Titan
Oriental Culture Holding Ltd stock declines despite market gains - Intellectia AI
Gelteq Limited (GELS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is It Too Early to Call Recovery in Eastern Silk Industries LimitedStock Buyback Announcements & Budget Friendly Growth - bollywoodhelpline.com
Gelteq (GELS) Stock Analysis Report | Financials & Insights - Benzinga
Gelteq Ltd Stock (GELS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.06%
1.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):